Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBLX
3601
DELISTED
Noble Midstream Partners LP
NBLX
| $2.97M | ﹤0.01% |
83,848
+78,709
| +1,532% | +$3.66M |
|
3602
Arlo Technologies
ARLO
$1.54B
| $2.97M | ﹤0.01% |
+204,469
| New | +$3.82M |
|
|
CHUY
3603
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.96M | ﹤0.01% |
112,954
-43,805
| -28% | -$1.29M |
|
|
EGN
3604
PUT
DELISTED
Energen
EGN
| $2.96M | ﹤0.01% |
34,400
-21,500
| -38% | -$1.64M |
|
3605
PUT
MSCI
MSCI
$41.4B
| $2.96M | ﹤0.01% |
16,700
+3,800
| +29% | +$660K |
|
3606
PUT
Roper Technologies
ROP
$39.5B
| $2.96M | ﹤0.01% |
10,000
-1,500
| -13% | -$442K |
|
3607
VeriSign
VRSN
$25.7B
| $2.96M | ﹤0.01% |
18,484
-84,016
| -82% | -$12.9M |
|
3608
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $2.95M | ﹤0.01% |
+52,767
| New | +$2.88M |
|
3609
Interface
TILE
$2.19B
| $2.95M | ﹤0.01% |
126,206
-163,306
| -56% | -$3.79M |
|
|
RP
3610
DELISTED
RealPage, Inc.
RP
| $2.94M | ﹤0.01% |
44,678
+20,357
| +84% | +$1.21M |
|
|
CEQP
3611
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.94M | ﹤0.01% |
80,086
-1,924
| -2% | -$70.4K |
|
3612
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
| $2.94M | ﹤0.01% |
38,500
+13,300
| +53% | +$1.08M |
|
3613
CALL
Terex
TEX
$7.76B
| $2.94M | ﹤0.01% |
73,600
+20,800
| +39% | +$846K |
|
|
JPUS
3614
JPMorgan Diversified Return US Equity ETF
JPUS
$469M
| $2.94M | ﹤0.01% |
+39,385
| New | +$2.91M |
|
3615
CALL
Grand Canyon Education
LOPE
$3.76B
| $2.93M | ﹤0.01% |
26,000
+14,800
| +132% | +$1.73M |
|
|
MTSC
3616
DELISTED
MTS Systems Corp
MTSC
| $2.93M | ﹤0.01% |
53,556
-7,790
| -13% | -$417K |
|
3617
CALL
American Eagle Outfitters
AEO
$2.71B
| $2.93M | ﹤0.01% |
118,100
+9,300
| +9% | +$235K |
|
3618
PUT
Lamb Weston
LW
$7.3B
| $2.93M | ﹤0.01% |
44,000
+37,000
| +529% | +$2.54M |
|
3619
VanEck Retail ETF
RTH
$259M
| $2.93M | ﹤0.01% |
+26,287
| New | +$2.81M |
|
|
INVX
3620
Innovex International
INVX
$2.18B
| $2.93M | ﹤0.01% |
55,986
+51,963
| +1,292% | +$2.71M |
|
|
JBTM
3621
PUT
JBT Marel
JBTM
$6.23B
| $2.92M | ﹤0.01% |
+24,500
| New | +$2.66M |
|
|
NTUS
3622
DELISTED
Natus Medical Inc
NTUS
| $2.92M | ﹤0.01% |
81,961
+74,593
| +1,012% | +$2.63M |
|
|
XENT
3623
CALL
DELISTED
Intersect ENT, Inc
XENT
| $2.92M | ﹤0.01% |
101,600
+61,600
| +154% | +$1.85M |
|
|
OPLN
3624
CALL
Openlane
OPLN
$4.33B
| $2.92M | ﹤0.01% |
129,194
+76,618
| +146% | +$1.77M |
|
3625
CALL
Matador Resources
MTDR
$6.64B
| $2.92M | ﹤0.01% |
88,300
+31,100
| +54% | +$993K |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.